Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading Companies to Watch Out - MediciNova, Mesoblast, Veru, Pluristem, Avalo, Boehringer Ingelheim, Genentech, Windtree
September 13, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading Companies to Watch Out - MediciNova,...
Chronic Refractory Cough Market to Observe Stupendous Growth by 2032, Assesses DelveInsight | Key Players to Watch Out - Merck, Kyorin, NeRRe, Bellus Health, GSK, Axalbion, Aldeyra, Genentech
September 06, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Chronic Refractory Cough Market to Observe Stupendous Growth by 2032, Assesses DelveInsight | Key Players to Watch Out - Merck, Kyorin, NeRRe,...
Multispecific Bispecific Trispecific Antibodies Market Opportunity and Clinical Development Insight
November 17, 2021 05:53 ET
|
KuicK Research
Delhi, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Delhi, India: In recent years, the palliative care and the treatment of diseases have seen a revolution with the arrival of more targeted therapies and...
Global Bispecific Antibodies Therapy Blincyto Hemlibra Antibody Therapeutics Market Size To Witness 118% Growth To Reach US$ 10 Billion By 2026
October 07, 2020 05:25 ET
|
KuicK Research
DELHI, India, Oct. 07, 2020 (GLOBE NEWSWIRE) -- "Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: Global Bispecific Antibody Market...
Immatics ernennt Arnd Christ zum Chief Financial Officer
September 29, 2020 07:00 ET
|
Immatics N.V.
Tübingen, Deutschland und Houston, Texas, 29. September 2020 – Immatics N.V. (NASDAQ: IMTX, „Immatics”), ein Unternehmen, das sich auf die Entwicklung und Herstellung von T-Zell-Immuntherapien für die...
Immatics Appoints Arnd Christ as Chief Financial Officer
September 29, 2020 07:00 ET
|
https://immatics.com/
Tuebingen, Germany and Houston, Texas, September 29, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell...
Global Bispecific Antibody Therapeutics Drug Market Sales Size Worth US$ 12 Billion By 2026
September 23, 2020 06:00 ET
|
KuicK Research
DELHI, India, Sept. 23, 2020 (GLOBE NEWSWIRE) -- :"Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: Global Bispecific Antibody Market...
Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for COVID-19 and other pulmonary diseases
August 24, 2020 02:00 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA; AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics...
Light Chain Bioscience successfully completes Factor VIII mimetic bispecific antibody discovery for Takeda
February 14, 2020 03:00 ET
|
Light Chain Bioscience - NovImmune SA
GENEVA, Switzerland, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, announced that it has achieved a...
U.S. Non-oncology Biopharmaceuticals Market to Surpass US$ 253.0 Billion by 2026
April 23, 2019 08:45 ET
|
CMI
SEATTLE, April 23, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. non-oncology biopharmaceuticals market size is estimated to be valued at US$ 116.0 Billion in 2018, and is...